The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Randall Hyer from Dynavax: Developing a Vaccine to Prevent Hepatitis B in Diabetes Patients
Research in the medical field covers a wide range of conditions and ways to not only treat them but also prevent them. Research is being done on a new vaccine for hepatitis B which has shown to be effective in patients with diabetes.
Gabriela Spencer-Bonilla from Mayo Clinic: How Can Social Networks Help Manage Diabetes
When people think of social networks their immediate reaction may be to think of web based networks and programs. A new recent study looked at the impact of having people to turn to for patients in the early stages of diabetes treatment and beyond.
James List: Janssen's Work in Diabetes Treatment Continues Forward Progress
The field of diabetes care is continually moving forward. Even as data was being presented at this year's meeting of the American Diabetes Association the future was at the forefront of many people's minds in an effort to help these patients even more.
Especially for children with diagnosed with type 1 diabetes their journey with the condition will last decades affecting not only themselves but those around them. This is also true for patients with type 2 diabetes and how they confront these challenges can affect their life outside of diabetes as well.